Related Experiment Video
Updated: Jul 11, 2025

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Factors Associated With Actionable Gastrointestinal Panel Results in Hospitalized Children
Erin C Ho1,2, Jillian M Cotter1,3, Jacob Thomas4
1Department of Pediatrics.
Insights
Gastrointestinal panel (GIP) testing for hospitalized children with acute gastroenteritis (AGE) is more likely to yield actionable results in older children, those with bloody stools, or with international travel history. This can guide testing decisions and reduce unnecessary procedures.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Diagnostics
- Health Services Research
Background:
- Acute gastroenteritis (AGE) is a common cause of hospitalization in children.
- The utility of gastrointestinal panel (GIP) testing in hospitalized pediatric patients with AGE is not well-defined.
- Unnecessary GIP testing can lead to increased healthcare costs and potential overtreatment.
Purpose of the Study:
- To identify clinical factors and indications for ordering GIP tests associated with actionable results in hospitalized children with AGE.
- To differentiate factors associated with actionable results in children with and without complex chronic conditions (CCC).
Main Methods:
- Cross-sectional study of pediatric patients hospitalized with diarrhea and GIP testing between 2015-2018.
- Multivariable regression analysis to assess associations between actionable GIP results and order indications, stool frequency, and demographics.
- Analysis stratified by complex chronic conditions (CCC) status.
Main Results:
- Actionable GIP results were more frequent in non-CCC patients compared to CCC patients.
- Older age (≥1 year) was associated with actionable results across both groups.
- In non-CCC patients, bloody stools and non-winter season were linked to actionable results; international travel correlated with non-Clostridioides difficile bacteria and parasites.
- No specific order indications were associated with actionable results in CCC patients.
Conclusions:
- Older age, bloody stools, and international travel history can help identify hospitalized children with AGE likely to have actionable GIP results.
- These findings may improve diagnostic stewardship and reduce unnecessary GIP testing in pediatric populations.
- Further prospective studies are needed to validate these predictive factors.
Objectives:
There is uncertainty regarding which hospitalized patients with acute gastroenteritis (AGE) benefit from gastrointestinal panel (GIP) testing. Unnecessary testing may lead to increased costs, overdiagnosis, and overtreatment. In general, AGE management and outcomes are most impacted if an actionable (bacterial or parasitic) result is obtained. We aimed to assess which clinical reasons for ordering GIP testing ("order indications") and patient factors were associated with actionable results.
Methods:
This is a cross-sectional study of pediatric patients hospitalized between 2015 and 2018 at a large pediatric health care system with diarrhea and a GIP performed. Multivariable regression analysis was used to determine associations between actionable GIP results and order indication, stool frequency, and demographics. Findings were evaluated in patients with complex chronic conditions (CCC) and non-CCC patients.
Results:
There were 1124 GIPs performed in 967 encounters. Non-CCC patients had more actionable results than CCC patients, and reasons for testing differed. Across both cohorts, age ≥1 year old was positively associated with actionable results. For non-CCC patients, actionable results were associated with "diarrhea with blood or pus" order indication and nonwinter season; international travel was associated with non-Clostridioides difficile bacteria and parasites. No order indications were associated with actionable results for CCC patients.
Conclusions:
Patient factors and order indications that may help identify children hospitalized for AGE with actionable GIP results include older age (regardless of CCC status), as well as bloody stools and international travel in previously healthy children. Prospective validation of these findings could help improve diagnostic stewardship and decrease unnecessary testing.
More Related Videos
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Other Disorders of Digestive System